| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 01/04/2006 | CN1717226A Warm poultice |
| 01/04/2006 | CN1715280A Aryl fused azapolycyclic compounds |
| 01/04/2006 | CN1715269A Cyanopyrrolidine derivatives |
| 01/04/2006 | CN1714859A Use of composition containing red-rooted salvia root in preparing medicine for treating anti-aspirin |
| 01/04/2006 | CN1714847A Use of medicine containing red-rooted salvia root in preparing medicine for treating anti-aspirin |
| 01/04/2006 | CN1714837A Use of medicine containing haw in preparing medicine for treating anti-aspirin |
| 01/04/2006 | CN1714836A Use of medicine in preparing medicine for treating anti-aspirin |
| 01/04/2006 | CN1714833A Use of medicine in preparing medicine for treating anti-aspirin |
| 01/04/2006 | CN1714831A Use of medicinal composition in preparing medicine for treating anti aspirin |
| 01/04/2006 | CN1714830A Use of medicinal preparation in preparing medicine for treating anti aspirin |
| 01/04/2006 | CN1714829A Use of medicine containing read-rooted salvia root in preparing medicine for treating anti aspirin |
| 01/04/2006 | CN1714828A Use of injection in preparing medicine for breating anti aspirin |
| 01/04/2006 | CN1714827A Use of medicine in preparing medicine for treating anti-aspirin |
| 01/04/2006 | CN1714826A Use of red-rooted salvia root and pseudo-ginseng preparation in preparing medicine for treating anti-aspirin |
| 01/04/2006 | CN1714825A Use of composition in preparing medicine for treating anti-aspirin |
| 01/04/2006 | CN1714824A Use of preparation in preparing medicine for treating anti-aspirin |
| 01/04/2006 | CN1714823A Use of dripping pill in preparing medicine for treating anti-aspirin |
| 01/04/2006 | CN1714822A Use of medicine containing ligusticum vallichii in preparing medicine for treating anti-aspirin |
| 01/04/2006 | CN1714821A Use of medicine containing boxwood in anti-aspirin medicine |
| 01/04/2006 | CN1714820A Use of medicine in preparing medicine for treating anti aspirin |
| 01/04/2006 | CN1714814A Use of medicine containing erigeron breviscapus in preparing medicine for treating anti aspirin |
| 01/04/2006 | CN1714812A Use of medicine containing pseudo-ginseng and borneol in preparing medicine for treating anti aspirin |
| 01/04/2006 | CN1234841C Nutrient vinegar |
| 01/04/2006 | CN1234712C 2-zminoalkyl-thieno [2, 3-D] pyrimidines |
| 01/04/2006 | CN1234711C Mikanolide derivatives,their preparation and its therapeutic uses |
| 01/04/2006 | CN1234705C New hydroxyl indoles, their use as phosphor diesterase 4 inhibitors and method for producing same |
| 01/04/2006 | CN1234693C Indazol compound for inhibiting protein kinase and medicine composition and their application |
| 01/04/2006 | CN1234688C 3-arylindole and their use as cb2 receptor agonists |
| 01/04/2006 | CN1234417C Pharmaceutical compositions comprising dendritic cells for immunotherapy of automimmune disease and treatment methods using the same |
| 01/04/2006 | CN1234413C Synergistic composition and its use |
| 01/04/2006 | CN1234404C Medicine for preventing and treating chronic exhaustion syndrome |
| 01/04/2006 | CN1234372C Use of bioactive fraction from cow urine distillate ( Go-mutra ) as a bio-enhancer of anti-infective, anti-cancer agents and nutrients |
| 01/04/2006 | CN1234366C Use of active vitamin D analogue in preparing medicine for treating hyperproliferative diseases |
| 01/04/2006 | CN1234362C Opioid agonist/antagonist combinations |
| 01/04/2006 | CN1234361C Method for preparing medicine of levo-stephandinine |
| 01/04/2006 | CN1234357C Antihypersensitive combination of valsartan and calcium channel blocker |
| 01/04/2006 | CN1234356C Leimaquban solid dispersion, preparation method and oral composition |
| 01/03/2006 | US6982353 C2-disubstituted indan-1-ol compounds, their derivatives, processes for their preparation, and their use as pharmaceuticals |
| 01/03/2006 | US6982320 Cytokine receptor common gamma chain like |
| 01/03/2006 | US6982278 For modulating a peroxisome proliferator activated receptor, particularly in the treatment of diabetes mellitus |
| 01/03/2006 | US6982277 Antitumor agents, antiinflammatory agents; for example 2-(2-imino-4,5,6,7-tetrahydro-1,3-benzothiazol-3(2H)-yl)-1-(4-methylphenyl) -1-ethanone, 2-(4-methylphenyl)-5,6,7,8-tetrahydrobenzo(d)-imidazo(2,1-b)thiazole |
| 01/03/2006 | US6982274 excellent inhibitory action on protein phosphatase (protein kinase), especially on JNK protein kinase; therapeutic or prophylactic agents for immunologic disease, inflammatory disease and/or neurodegenerative disease |
| 01/03/2006 | US6982271 selective norepinephrine and serotonin reuptake inhibitor (SSNRI); antidepressant; treating cocaine addiction; "N3 bridged" tropanes |
| 01/03/2006 | US6982270 1-Phenyl-2-oxo-3,4-dihydro-6-phenylaminoquinazoline for example; cytokine suppressive anti-inflammatory drugs; combination therapy |
| 01/03/2006 | US6982268 Useful in the treatment of a variety of central nervous system disorders in humans including anxiety, depression, sleep disorders, attention deficit disorder, or Alzheimer's dementia |
| 01/03/2006 | US6982266 N-(4-indol-5-yloxyphenyl){4-[6-methoxy-7-(2-methoxyethoxy)quinazolin-4-yl]piperazinyl}carboxamide for example; antiproliferative agents which inhibit phosphorylation of kinases such as tyrosine kinase; cancer, arteriosclerosis |
| 01/03/2006 | US6982263 Peptidyl carbamates; treatments for osteoporosis and autoimmune diseases |
| 01/03/2006 | US6982262 Combination of cyamemazine and an atypical neuroleptic |
| 01/03/2006 | US6982261 A progesterone receptor antagonist for providing progestational therapy, treating cancer of breast, uterine, ovarian, endometrial, or prostate, providing contraceptives, hormone replacement therapy |
| 01/03/2006 | US6982258 Low-calcemic oxime analogs of 1α,25-dihydroxy vitamin D3 |
| 01/03/2006 | US6982253 Liquid formulation of decitabine and use of the same |
| 01/03/2006 | US6982157 Drug combinations comprising (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methylsulfonyl)amino] pyrimidin-5-yl] (3r,5s) -3,5-dihydroxyhept-6-enoic acid and an inhibitor, inducer or substrate of p450 isoenzyme 3A4 |
| 01/03/2006 | US6982099 Composition and method for smoke detoxification |
| 01/03/2006 | CA2329005C Folic acid-containing pharmaceutical compositions, and related methods and delivery systems |
| 01/03/2006 | CA2187449C Anti-cancer compounds containing cyclopentaquinazoline ring |
| 01/03/2006 | CA2176117C Generation of high titers of recombinant aav vectors |
| 01/03/2006 | CA2162586C Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells |
| 01/03/2006 | CA2158937C Recombinant alphavirus vectors |
| 12/29/2005 | WO2005123767A1 Peptide-based compounds |
| 12/29/2005 | WO2005123745A1 Tricyclic compounds |
| 12/29/2005 | WO2005123725A1 Novel compound having lipase inhibitory activity |
| 12/29/2005 | WO2005123697A1 Quinazoline derivatives |
| 12/29/2005 | WO2005123671A1 Pyrrole derivative |
| 12/29/2005 | WO2005123120A1 Sustained release vaccine composition |
| 12/29/2005 | WO2005123068A2 Methods of dealying alzheimer’s disease progression using a beta-amyloid precursor protein inhibitor and a hmg coa reductase inhibitor |
| 12/29/2005 | WO2005123062A1 Inflammation inhibitor comprising zinc salt of acylamino acid |
| 12/29/2005 | WO2005123058A1 Antiaging agent |
| 12/29/2005 | WO2005062828A3 New compounds useful as metal chelators |
| 12/29/2005 | WO2003033671A3 Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions |
| 12/29/2005 | WO2003012122A3 Crystallized structure of type iv collagen nc1 domain hexamer |
| 12/29/2005 | WO2002099040A3 Igs as modifiers of the p53 pathway and methods of use |
| 12/29/2005 | US20050289660 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use |
| 12/29/2005 | US20050289658 System for regulating in vivo the expression of a transgene by conditional inhibition |
| 12/29/2005 | US20050289657 Diagnostic and therapeutic use of an atp-binding cassette gene and protein for neurodegenerative diseases |
| 12/29/2005 | US20050288651 Apparatus with weeping tip and method of use |
| 12/29/2005 | US20050288501 Reducing a 2-(protected amino)-3-(piperazin-1-yl, N-morpholinyl, or N-thiomorpholinyl) propanoate, deprotecting the amine, and reacting with t-butylisothiocyanate |
| 12/29/2005 | US20050288490 Polyether with glycerol backbone; capable of being labeled |
| 12/29/2005 | US20050288487 Human mast cell-expressed membrane proteins |
| 12/29/2005 | US20050288376 Bicyclyl or heterobicyclylmethanesulfonylanimo-substituted N-hydroxyformamides |
| 12/29/2005 | US20050288366 Administering N-(4-carboxybutyl)-N-(p-carboxybenzyl)-benzyl- or phenethyl-amine derivatives: 4-({(4-Carboxybutyl)[3-(4-cyclohexylphenoxy)benzyl]amino}methyl)-benzoic acid; stimulate soluble guanylate cyclase also via a novel mechanism of action which takes place without involvement of the heme group |
| 12/29/2005 | US20050288357 e.g. 4-(2-{2-[4-hydroxy-4-(1-propylcyclobutyl)but-1-enyl]-5-oxopyrrolidin-1-yl}ethyl)benzoic acid; antiinflammatory, hypotensive, antiulcer agent |
| 12/29/2005 | US20050288355 Combination therapy wherein a serotonin reuptake inhibitor is used |
| 12/29/2005 | US20050288353 Methods of modulating c-kit tyrosine protein kinase function with indolinone compounds |
| 12/29/2005 | US20050288350 Useful in female hormone replacement therapy and as modulators of fertility; therapy of dysfunctional uterine bleeding, dysmenorrhea, endometriosis, leiomyomas (uterine fibroids), hot flashes, mood disorders, meningiomas, cancer; 6-(bis-2,2,2-Trifluoroethyl)amino-4-trifluoromethylcoumarin |
| 12/29/2005 | US20050288339 Medicinal compositions containing diuretic and insulin resistance-improving agent |
| 12/29/2005 | US20050288335 Triamide-substituted heterobicyclic compounds |
| 12/29/2005 | US20050288325 Therapy for andropause using estrogen agonists/antagonists and testosterone |
| 12/29/2005 | US20050288323 Octahydro-indolizine and quinolizine and hexahydro-pyrrolizine |
| 12/29/2005 | US20050288322 Cyclizing 2,6-diaminopyridine in sulfuric acid with malic acid to form 2-amino-7-hydroxy-1,8-naphthyridine; phthalimidating the naphthyridine and replacing the OH with Cl; reducing the product to form the hydroxyindolinone derivative and etherifying with 5-methyl-2-oxo-hexyltriphenylphosphonium halide |
| 12/29/2005 | US20050288321 Alzheimer's disease ; 3-(2,3-dihydro-5,6-difluorobenzofur-7-yl)-4-[1-(piperidin-4-yl)-1H-indol-3-yl]pyrrole-2,5-dione; stimulating bone deposition |
| 12/29/2005 | US20050288320 Induce biosymthesis of cytokines, interferons, tumor necrosis factor; antitumor agents; viricides; chemical intermediates |
| 12/29/2005 | US20050288313 Synergistically combined with immunomodulators or antiinflammtory agents; treating rheumatoid arthritis; inhibiting organ transplant rejection; Janus Kinase 3 inhibitors such as CP 690550, 3-{4-Methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile |
| 12/29/2005 | US20050288312 Bicyclic pyridine and pyrimidine p38 kinase inhibitors |
| 12/29/2005 | US20050288303 Cyclic protein tyrosine kinase inhibitors |
| 12/29/2005 | US20050288297 {4-[6-methoxy-7-(3-piperidylpropoxy)quinazolin-4-yl]piperazinyl}-N-[4-(methylethoxy)phenyl]carboxamide; inhibits phosphorylation of platelet-derived growth factor receptor to hinder abnormal cell growth/wandering; cancer; arteriosclerosis, vascular reobstruction, cancer and glomerulosclerosis |
| 12/29/2005 | US20050288293 8-hydroxy-1-oxo-tetrahydropyrrolopyrazine compounds useful as hiv integrase inhibitors |
| 12/29/2005 | US20050288285 Substituted 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses |
| 12/29/2005 | US20050288275 New compounds |
| 12/29/2005 | US20050288274 Treating rhinitis by topically administering an epinastine solution to the nasal mucous membrane |
| 12/29/2005 | US20050288265 Novel combination of glucocorticoids and pde-4 inhibitors for treating respiratory diseases, allegic diseases, asthma and copd |